Medicamen Biotech Q4 Results

  • BSE: 531146
  • NSE: MEDICAMEQ
  • ISIN: INE646B01010
  • Sector: Biotechnology & Drugs
BSE
442.7-5.35 (-1.19%)
Volume1.24 K
Updated: Mon 25 Nov, 2024 | 15:28:51
NSE
435.1-11.65 (-2.61%)
Volume23.85 K
Updated: Mon 25 Nov, 2024 | 15:29:47
Today: 434.70
456.85
52-Wk: 356.75
661.85

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Medicamen Biotech Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 47.3235.58-%38.67-%
    Selling/ General/ Admin Expenses Total 8.395.67-%5.78-%
    Depreciation/ Amortization 1.771.60-%1.62-%
    Other Operating Expenses Total 9.587.06-%4.74-%
    Total Operating Expense 43.3431.31-%33.80-%
    Operating Income 3.984.28-%4.87-%
    Net Income Before Taxes 2.664.22-%4.36-%
    Net Income 2.133.76-%3.89-%
    Diluted Normalized EPS 1.612.98-%3.28-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts